Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1053 | 931 | 1053 | 1024 | 1242 | 1541 |
Fund Return | 5.32% | -6.95% | 5.32% | 0.78% | 4.43% | 4.42% |
Place in category | 264 | 189 | 264 | 291 | 306 | 304 |
% in Category | 36 | 27 | 36 | 53 | 54 | 75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GuidePath Growth Allocation Svc | 1.39B | 17.51 | 4.29 | 8.44 | ||
GuideMark Large Cap Core Service | 776.55M | 22.38 | 7.38 | 11.68 | ||
GuidePath Tactical Allocation Svc | 655.74M | 20.40 | 9.06 | 7.14 | ||
GuidePath Conservative Allocation | 544.31M | 8.17 | 1.59 | 4.03 | ||
GuideMark Emerging Markets Service | 46.96M | 8.76 | -0.37 | 4.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 206B | 5.09 | 0.61 | 5.00 | ||
Vanguard Total Intl Stock Index Adm | 75.27B | 5.14 | 0.67 | 5.06 | ||
Fidelity International Index Inst | 51.28B | 3.71 | 1.71 | 5.38 | ||
Fidelity Series Global ex US Index | 50.22B | 5.35 | 0.85 | 4.86 | ||
Strategic Advisers International I | 44.17B | 5.63 | 0.87 | 6.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares MSCI EAFE | US4642874659 | 2.69 | 75.06 | -1.52% | |
Novo Nordisk B | DK0062498333 | 1.73 | 632.3 | +0.37% | |
Novartis | CH0012005267 | 1.01 | 91.09 | -0.60% | |
AstraZeneca | GB0009895292 | 1.00 | 10,982.0 | -0.05% | |
ASML Holding | NL0010273215 | 0.99 | 725.30 | -1.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review